- Home
- SST vs KRRO Comparison
SST vs KRRO Comparison
Compare SST & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SST | KRRO |
|---|---|---|
| Founded | 2013 | 2014 |
| Country | United States | United States |
| Employees | 300 | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.4M | 101.1M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | SST | KRRO |
|---|---|---|
| Price | $2.95 | $10.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 12 |
| Target Price | $10.00 | ★ $47.10 |
| AVG Volume (30 Days) | 6.1K | ★ 143.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 82.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,271,000.00 |
| Revenue This Year | N/A | $145.97 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.29 | $5.20 |
| 52 Week High | $11.30 | $55.89 |
Technical Indicators
Market Signals| Indicator | SST | KRRO |
|---|---|---|
| Relative Strength Index (RSI) | 33.20 | 44.65 |
| Support Level | $0.34 | $10.55 |
| Resistance Level | $3.57 | $12.54 |
| Average True Range (ATR) | 0.25 | 0.85 |
| MACD | -0.00 | -0.13 |
| Stochastic Oscillator | 9.10 | 16.20 |
Price Performance
Historical ComparisonAbout SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment. Geographically, it operates in United States and Other countries.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.